Market closedNon-fractional

Enfusion/ENFN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Enfusion

Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.

Ticker

ENFN

Sector

Technology

Trading on

NYSE

Industry

Software

Headquarters

Chicago, United States

Employees

1,102

Enfusion Metrics

BasicAdvanced
$846M
Market cap
363.74
P/E ratio
$0.03
EPS
0.97
Beta
-
Dividend rate
$846M
0.97
4.075
3.667
13.229
18.711
3.31%
4.18%
363.737
4.476
14.23
14.23
49.649
15.55%
-13.74%
28.62%

What the Analysts think about Enfusion

Analyst Ratings

Majority rating from 8 analysts.
Hold

Enfusion Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1.04% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$48M
3.45%
Net income
-$500K
-183.33%
Profit margin
-1.04%
-180.62%

Enfusion Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 65.52%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.04
$0.04
$0.04
$0.06
-
Expected
$0.04
$0.05
$0.05
$0.04
$0.06
Surprise
-4.11%
-12.50%
-23.81%
65.52%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Enfusion stock?

Enfusion (ENFN) has a market cap of $846M as of July 23, 2024.

What is the P/E ratio for Enfusion stock?

The price to earnings (P/E) ratio for Enfusion (ENFN) stock is 363.74 as of July 23, 2024.

Does Enfusion stock pay dividends?

No, Enfusion (ENFN) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next Enfusion dividend payment date?

Enfusion (ENFN) stock does not pay dividends to its shareholders.

What is the beta indicator for Enfusion?

Enfusion (ENFN) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Enfusion stock

Buy or sell Enfusion stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing